Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 has become a serious challenge for medicine and science. Analysis of the molecular mechanisms associated with the clinical manifestations and severity of COVID-19 has identified several key points of immune dysregulation observed in SARS-CoV...
Guardado en:
Autores principales: | Olexandr Kamyshnyi, Victoriya Matskevych, Tetyana Lenchuk, Olha Strilbytska, Kenneth Storey, Oleh Lushchak |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d8b5f4dd35445109b1f2f3646cdef92 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010) -
Tissue environment, not ontogeny, defines murine intestinal intraepithelial T lymphocytes
por: Alejandro J Brenes, et al.
Publicado: (2021) -
Metformin Induces Ultrastructural Alterations in Hepatocytes of Spontaneously Hypertensive Rats
por: Gharbaran,Rajendra
Publicado: (2014) -
Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
por: Theodore J. Cory, et al.
Publicado: (2021) -
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
por: Mojdeh Soltani, et al.
Publicado: (2021)